Volume Movers (Radian Group Inc, American Realty Capital Properties Inc CARDIOME PHARMA CORP, Prana Biotechnology Limited)

Houston, TX -- (SBWIRE) -- 03/04/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Radian Group Inc(NYSE:RDN) jumped 5.23% and is trading at $9.65. Radian Group Inc. (Radian Group) is a credit enhancement company with a focus on domestic, first-lien residential mortgage insurance (first-lien). The Company’s business segments are mortgage insurance and financial guaranty. Its mortgage insurance segment provides credit-related insurance coverage, principally through private mortgage insurance, and risk management services to mortgage lending institutions.

Can RDN Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

American Realty Capital Properties Inc(NASDAQ:ARCP) is lower 4.12% and is trading at $12.57. American Realty Capital Properties, Inc. is a real estate investment trust (REIT). The Company owns and acquires single-tenant, freestanding commercial real estate that is net leased on a medium-term basis, to investment grade credit rated and other creditworthy tenants. Its business is conducted through ARC Properties Operating Partnership, L.P.

How Should Investors Trade ARCP After The Recent Volatile Moves? Find Out Here

CARDIOME PHARMA CORP(NASDAQ:CRME) added 4.55% and is trading at $0.460. Cardiome Pharma Corp. (Cardiome) is a research-based biopharmaceutical company. The Company is focused on the discovery, development and commercialization of new therapies. It has one product, BRINAVESS, approved for marketing in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

Is CRME Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) jumped 13.11% and is trading at $2.76. Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer’s disease.

Can PRAN Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com